Aşılama Sonrası Nörolojik İstenmeyen Etkiler
Özet
Bağışıklama, enfeksiyon hastalıklarına karşı en etkili halk sağlığı müdahalesi olup, günümüzde kullanılan aşılar oldukça güvenli bir profile sahiptir. Aşı sonrası görülen nörolojik istenmeyen etkiler son derece nadir olup, çoğu zaman aşıya değil, rastlantısal tıbbi olaylara veya altta yatan durumlara atfedilmektedir. Bilimsel veriler, aşılar ile otizm veya benzeri nörolojik hastalıklar arasında bir nedensellik ilişkisi olmadığını açıkça ortaya koymaktadır. Bu nedenle aşılamanın bireysel ve toplumsal faydaları, oluşabilecek çok nadir yan etki risklerinden çok daha üstündür.
Immunization serves as the most effective public health intervention for preventing infectious diseases, and modern vaccines possess an excellent safety profile. Neurological adverse effects following vaccination are extremely rare and are frequently coincidental or attributable to pre-existing conditions rather than the vaccines themselves. Scientific evidence consistently demonstrates no causal link between vaccines and neurodevelopmental disorders like autism. Consequently, the public health benefits of vaccination significantly outweigh the minimal risks associated with these rare adverse events.
Referanslar
World Health Organization. Global manual on surveillance of adverse events following immunization, 2016 update. World Health Organization (2014). (30/06/2021 tarihinde https://apps.who.int/iris/handle/10665/206144 adresinden ulaşılmıştır).
Türkiye Cumhuriyeti Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü. Aşı sonrası istenmeyen etkiler genelgesi, 2009. (28/06/2021 tarihinde https://www.saglik.gov.tr/TR,11136/asi-sonrasi-istenmeyen-etkiler-genelgesi-2009.html adresinden ulaşılmıştır).
Miravalle AA, Schreiner T. Neurologic complications of vaccinations. Handb Clin Neurol. 2014;121:1549-57.
Gasparini R, Panatto D, Lai PL, Amicizia D. The "urban myth" of the association between neurological disorders and vaccinations. J Prev Med Hyg. 2015;56(1):E1-8.
Dudley MZ, Halsey NA, Omer SB, et al. The state of vaccine safety science: systematic reviews of the evidence. Lancet Infect Dis. 2020; 20(5):e80-9.
Velipaşaoğlu S. Bağışıklama Programları ve Güvenli Aşı Uygulamaları. Gökçay G, editör. Aşılar. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.6-11.
World Health Organization. Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification (Second edition). World Health Organization (2018). (12/08/2021tarihinde https://www.who.int/vaccine_safety/publications/aefi_manual.pdf?ua=1 adresinden ulaşılmıştır).
American Academy of Pediatrics. Active immunization. In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. Red Book: 2021 Report of the Committee on Infectious Disease. 32 st ed. Itasca, IL: American Academy of Pediatrics; 2021. p.42-51.
Tiwari TSP, Wharton M. Diphtheria Toxoid. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM,eds. Plotkin's Vaccines. 7th ed. Philadelphia:Elsevier; 2018. p.261-75.e7.
Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018 ;67(2):1-44.
T.C Sağlık Bakanlığı. Halk sağlığı Genel Müdürlüğü. Aşı Portalı. (10/07/2021tarihinde https://asi. saglik.gov.tr/asi-takvimi2 adresinden ulaşılmıştır).
T.C Sağlık Bakanlığı Temel Sağlık Hizmetleri Müdürlüğü, Genişletilmiş Bağışıklama Programı Genelgesi, 2009. (28/06/2021 tarihinde https://www.saglik.gov.tr/TR,11137/genisletilmis-bagisiklama-programi-genelgesi-2009.html adresinden ulaşılmıştır).
American Academy of Pediatrics. Pertussis (Whooping Cough). In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2018 Report of the Committee on Infectious Disease. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018. p.620-34.
Reyes IS, Hsieh DT, Laux LC, Wilfong AA. Alleged cases of vaccine encephalopathy rediagnosed years later as Dravet syndrome. Pediatrics. 2011;128(3):e699-702.
Pruna D, Balestri P, Zamponi N, et al. Epilepsy and vaccinations: Italian guidelines. Epilepsia. 2013; 54(Suppl 7):13-22.
BC Centre For Disease Control. Adverse Events Following Immunization. (06/08/2021 tarihinde http://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Part_5_AEFI.pdf adresinden ulaşılmıştır).
World Health Organization. Immunization in practice: a practical guide for health staff, 2015 update. (06/08/2021tarihinde https://apps.who.int/iris/bitstream/handle/10665/193412/9789241549097_eng.pdf?sequence=1&isAllowed=y adresinden ulaşılmıştır).
Velipaşaoğlu S. Özel Durumlarda Bağışıklama. Gökçay G, Beyazova U, editörler. İlk Beş Yaşta Çocuk Sağlığı İzlemi. 2.Baskı. İstanbul: Nobel Tıp Kitabevleri; 2020. p.595-610.
Huang WT, Gargiullo PM, Broder KR, et al; Vaccine Safety Datalink Team. Lack of association between acellular pertussis vaccine and seizures in early childhood. Pediatrics. 2010;126(2):263-9.
Türkiye Cumhuriyeti Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü. Aşı sonrası istenmeyen etkiler genelgesi, EK 2 vaka tanımları. 2009. (30/06/2021 tarihinde https://www.saglik.gov.tr/TR,11136/asi-sonrasi-istenmeyen-etkiler-genelgesi-2009.html adresinden ulaşılmıştır).
Braun MM, Terracciano G, Salive ME, et al. Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization. Pediatrics. 1998 ;102(5): E52.
Committee to Review Adverse Effects of Vaccines; Institute of Medicine. Adverse Effects of Vaccines: Evidence and Causality. Stratton K, Ford A, Rusch E, Clayton EW, editors. Washington (DC): National Academies Press (US); 2011.
Tuttle J, Chen RT, Rantala H, Cherry JD, Rhodes PH, Hadler S. The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health. 1997;87(12):2045-8.
Velipaşaoğlu S. Aşı Kontrendikasyonları ve Önlem Alınarak Aşı Uygulanması Gereken Durumlar. Gökçay G, Beyazova U, editörler. İlk Beş Yaşta Çocuk Sağlığı İzlemi. 2.Baskı. İstanbul: Nobel Tıp Kitabevleri; 2020. p.479-83.
American Academy of Pediatrics. Poliovirus Infections. In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. Red Book: 2021 Report of the Committee on Infectious Disease. 32 st ed. Itasca, IL: American Academy of Pediatrics; 2021. p.601-7.
T.C Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu Başkanlığı, Polio İmportasyon Planı Genelgesi. (17/07/2021 tarihinde https://asirehberi.saglik.gov.tr/genelgeler/polio-genelgesi adresinden ulaşılmıştır).
Prevots DR, Burr RK, Sutter RW, Murphy TV; Advisory Committee on Immunization Practices. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49(RR-5): 1-22; quiz CE1-7.
World Health Organization. Circulating vaccine-derived poliovirus type 2 – Global update, 26 March 2021. (17/07/2021 tarihinde https://www.who.int/emergencies/disease-outbreak-news/item/circulating-vaccine-derived-poliovirus-type-2-global-update adresinden ulaşılmıştır).
World Health Organization. Polio vaccines: WHO position paper, March 2016-recommendations. Vaccine. 2017;35(9):1197-9.
Duyan Çamurdan A. İnfluenza Aşısı. Gökçay G, Beyazova U, editörler. İlk Beş Yaşta Çocuk Sağlığı İzlemi. 2.Baskı. İstanbul: Nobel Tıp Kitabevleri; 2020. p.529-35.
Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barré syndrome. Drug Saf. 2009;32(4):309-23.
Salmon DA, Proschan M, Forshee R, et al. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013 ;381(9876):1461-8.
Kwong JC, Vasa PP, Campitelli MA,et al. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis. 2013;13(9):769-76.
American Academy of Pediatrics. Influenza. In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. Red Book: 2021 Report of the Committee on Infectious Disease. 32 st ed. Itasca, IL: American Academy of Pediatrics; 2021. p.447-56.
Grohskopf LA, Alyanak E, Broder KR, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season. MMWR Recomm Rep. 2020 ;69(8):1-24.
Principi N, Esposito S. Vaccines and febrile seizures. Expert Rev Vaccines. 2013;12(8):885-92.
Duffy J, Weintraub E, Hambidge SJ, et al. Febrile Seizure Risk After Vaccination in Children 6 to 23 Months. Pediatrics. 2016;138(1):e20160320.
Özbörü Aşkan Ö, Boran P. Kızamık-kızamıkçık-kabakulak aşısı. Gökçay G, editör. Aşılar. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.99-107.
American Academy of Pediatrics. Measles. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2018 Report of the Committee on Infectious Disease. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018. p.537-50.
McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 ;62(RR-04):1-34.
Fisher DL, Defres S, Solomon T. Measles-induced encephalitis. QJM. 2015;108(3):177-82.
Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev. 2020;4(4):CD004407.
Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998 ;351(9103):637-41. Retraction in: Lancet. 2010;375(9713)445.
Godlee F, Smith J, Marcovitch H. Wakefield's article linking MMR vaccine and autism was fraudulent. BMJ. 2011;342:c7452.
Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev. 2012 ;2012(2):CD004407 Update in: Cochrane Database Syst Rev. 2020 Apr 20;4:CD004407.
Hviid A, Hansen JV, Frisch M, Melbye M. Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. Ann Intern Med. 2019 ;170(8):513-20.
Bonnet MC, Dutta A, Weinberger C, Plotkin SA. Mumps vaccine virus strains and aseptic meningitis. Vaccine. 2006;24(49-50):7037-45.
American Academy of Pediatrics. Varicella-Zoster Virus Infections. In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. Red Book: 2021 Report of the Committee on Infectious Disease. 32 st ed. Itasca, IL: American Academy of Pediatrics; 2021. p.831-43.
Galea SA, Sweet A, Beninger P, et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis. 2008 ;197 Suppl 2:S165-9.
Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020 ;69(9):1-41.
Yih WK, Weintraub E, Kulldorff M. No risk of Guillain-Barré syndrome found after meningococcal conjugate vaccination in two large cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(12):1359-60.
Kroger A, Bahta L, Hunter P. General Best Practice Guidelines for Immunization. Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). Updated May 4, 2021. (21/07/2021 tarihinde https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/downloads/general-recs.pdf adresinden ulaşılmıştır).
Mouchet J, Salvo F, Raschi E, et al. Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis. Vaccine. 2018 ;36(12):1548-55.
Sestili C, Grazina I, La Torre G. HBV vaccine and risk of developing multiple sclerosis: a systematic review and meta-analysis. Hum Vaccin Immunother. 2021;17(7):2273-78.
Hicks DJ, Fooks AR, Johnson N. Developments in rabies vaccines. Clin Exp Immunol. 2012;169(3):199-204.
American Academy of Pediatrics. Rabies. In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. Red Book: 2021 Report of the Committee on Infectious Disease. 32 st ed. Itasca, IL: American Academy of Pediatrics; 2021. p.619-26.
World Health Organization. WHO expert consultation on rabies: third report. World Health Organization (2018). (25/06/2021 tarihinde https://apps.who.int/iris/handle/10665/272364 adresinden ulaşılmıştır).
Manning SE, Rupprecht CE, Fishbein D, et al; Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC). Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008 ;57(RR-3):1-28.
T.C Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü. Aşı Portali. Aşı içerikleri. (25/06/2021 tarihinde https://asi.saglik.gov.tr/genel-bilgiler/36-asi-icerikleri.html adresinden ulaşılmıştır).
Price CS, Thompson WW, Goodson B, et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics. 2010;126(4):656-64.
Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccine and autism. JAMA. 2003 ;290(13):1763-6.
Institute of Medicine (US) Immunization Safety Review Committee. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Stratton K, Gable A, McCormick MC, editors. Washington (DC): National Academies Press (US); 2001.
Centers for Disease Control and Prevention (CDC). Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep. 1999;48(26):563-5.
